NCT03927885View on ClinicalTrials.gov

Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 30, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
Interventions
OTHER

Placebo Administration

Given open labeled placebo PO

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Waiting List

Assigned to a waiting list

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER